Vertos Medical’s $23 Million Series E Highlights Minimally Invasive Trend In Spine Surgery
A $23 million Series E financing round that closed in June will allow Vertos Medical Inc. to further expand commercialization of its minimally invasive mild procedure for patients with lumbar spinal stenosis.
You may also be interested in...
The Medicare agency is requesting public comment on the clinical evidence of short-term and long-term health benefit outcomes of this procedure to diagnose and treat lumbar spinal stenosis.
South Korea has formulated new detailed policy measures to support the formation of major bioclusters, which will offer tax and other incentives in a bid to lure foreign firms and talent.
Abrysvo is recommended for use in pregnant people 32-36 weeks gestation if administered from September to January. For infants whose mothers were not vaccinated in this window, nirsevimab is recommended for prevention of respiratory syncytial virus infection.